1 Min Read
Nov 13 (Reuters) - MOBERG PHARMA:
* Q3 EBITDA SEK 36.0 MILLION VERSUS 29.0 MILLION YEAR AGO
* Q3 REVENUE SEK 108.3 MILLION VERSUS SEK 104.1 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.